Astria Therapeutics, Inc. (ATXS) Reports In-Line Q3 EPS

Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q3 EPS of ($0.42), in-line with the analyst estimate of ($0.42).

For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• OSR Health faces Nasdaq delisting, plans appeal and $15M put option
• Can Anthropic actually match or beat SpaceX’s IPO? Numbers say "Yes, but"